News
An exclusive opportunity to visit one-on-one with University of Arizona Arthritis Center faculty, physicians and scientists to learn about leading-edge research being conducted at the center.
World-renowned neurobiologists and leaders in chemistry will discuss the brain circuits underlying acute and chronic pain, reward, motivation and addiction, and the development of chemical probes as potential novel therapies. The symposium is co-sponsored by the University of Arizona College of Medicine - Tucson Department of Pharmacology and Interim Dean Irving Kron, MD.
Pain specialists at the University of Arizona and Banner – University Medicine are trying to reduce the use of opioids for patients suffering from chronic non-cancer pain by utilizing alternatives and complementary methods, and a large array of pain intervention procedures.
University of Arizona researchers will compete in a Shark Tank-style competition, demonstrate their medical technology and more during Research Day, a first-of-its-kind event coordinated by the UA College of Medicine – Tucson.
Roberta Diaz Brinton, PhD, inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, received $5.9 million from the National Institute on Aging to study the role of gender in Alzheimer’s disease and develop precision medicine interventions to prevent — and potentially reverse — the course of the disease in both women and men.
Accomplished physician-scientist and transformational leader Dr. Kenneth Ramos, an expert on genetics and genomic medicine, will deliver the keynote address at the University of Arizona Arthritis Center’s 17th annual conference for those living with arthritis — and those who care for them.
Roberta Diaz Brinton, PhD, inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, is one of six international researchers awarded funding through the Alzheimer’s Association's Part the Cloud program to support early phase human trials of potential therapies to save brain cells.
The UA's focus has been on helping people with chronic pain without using narcotics or other addictive drugs.
The three-year Arizona Biomedical Research Commission Awards will fund research relating to neuropathic and cancer pain, migraines, opioids, antibiotics, antivirals, sinusitis, obesity, diabetes, Parkinson’s disease, pulmonary disease and pediatric acute-onset neuropsychiatric syndrome.
Free and open to the public, the lecture by Drs. Mohab M. Ibrahim and Todd W. Vanderah—members of one of the largest groups in the world studying chronic pain and treatment alternatives—will explore their exciting research on medications and therapies designed to inhibit chronic pain without unwanted side effects, including addiction.
Roberta Diaz Brinton, PhD, director of the Center for Innovation in Brain Science at UAHS, received a $450,000 grant to advance her groundbreaking clinical development of the first regenerative therapeutic for Alzheimer’s disease.
The UA's Todd Vanderah and his colleagues have been studying the class of chemical compounds, which may help people find pain relief brought about by metastatic breast cancer.
Two UA researchers say that finding the ideal molecule could open the door to therapeutic drugs to treat diseases such as ALS.
Known for his pioneering research on the molecular and circuit origins of chronic pain and discoveries that may lead to new treatments, Dr. Porreca received the award and delivered the Ronald Melzack Distinguished Lecture during the 16th World Congress on Pain®, attended by the world’s top pain researchers and clinicians.
Banner-University Medical Center Phoenix and Banner-University Medical Center Tucson have each been named to U.S. News & World Report’s Best Hospital ranking, and nationally recognized for specialty services.
Dr. Vanderah, who had been serving as interim department head since 2011, has accepted the Pharmacology department head position at the University of Arizona College of Medicine – Tucson.
The title of Regents Professor is reserved for full professors whose exceptional achievements merit national and international distinction.
